Dihydrodiol Dehydrogenases and Polycyclic Aromatic Hydrocarbon Activation: Generation of Reactive and Redox Active o-Quinones

Gelboin H. V., 1980, Physiol. Rev., 60, 10.1152/physrev.1980.60.4.1107

Conney A. H., 1982, Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. G. H. A. Clowes Memorial Lecture. Cancer Res. 42, 4875−4917

Harvey R. G., 1991, in Polycyclic Aromatic Hydrocarbons:  Chemistry and Carcinogenicity

Thakker D. R., 1976, Proc. Natl. Acad. Sci. U.S.A. 73

Yang, S. K., McCourt, D. W., Roller, P. P., and Gelboin, H. V. (1976) Enzymatic conversion of benzo[a]pyrene leading predominantly to the diol-epoxide r-7,t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene through a single enantiomer of r-7,t-8-dihydroxy-7,8-dihydrobenzo[a]pyrene.Proc. Natl. Acad. Sci. U.S.A.73, 2594−2598.

Jeffrey A. M., 1976, J. Am. Chem. Soc., 98, 10.1021/ja00434a060

Shou M., 1992, Contribution of dihydrodiol dehydrogenase to the metabolism of (±)-trans-7,8- 15 dihydroxy-7,8-dihydrobenzo[a]pyrene in fortified rat liver subcellular fractions. Carcinogenesis 13, 1575−1582

Cavalieri E. L., 1995, Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons. Xenobiotica 25, 677−688

Chen L., 1996, Expanded analysis of benzo[a]pyrene-DNA adducts formed in vitro and in mouse skin:  their significance in tumor inititation. Chem. Res. Toxicol. 9, 897−903

Smithgall T. E., 1988, J. Biol. Chem., 263

Penning T. M., 1996, Chem. Res. Toxicol., 9, 92, 10.1021/tx950055s

Yang S. K., 1977, Enzymatic mechanism of benzo[a]pyrene conversion to phenols and diols and an improved high-pressure liquid chromatographic separation of benzo[a]pyrene derivatives. Biochemistry 16, 3680−3687

Osborne M. R., 1976, Int. J. Cancer, 18, 10.1002/ijc.2910180315

Jennette K. W., 1977, Nucleoside adducts from the in vitro reaction of benzo[a]pyrene-7,8-dihydrodiol-9,10-oxide or benzo[a]pyrene-4,5-oxide with nucleic acids. Biochemistry 16, 932−938

Koreeda M., 1978, RNA and protein of mouse skin occurs with high stereoselectivity. Science 199, 778−781.

Nagao M., 1978, Polycyclic Hydrocarbons and Cancer (Ts'O, 121

Malaveille C., 1977, Mutagenicity of isomeric diol-epoxides of benzo[a]pyrene and benz[a]anthracene in S. typhimurium TA98 and TA100 and in V79 Chinese hamster cells. Mutat. Res. 44, 313−326

Newbold R. F., 1976, Nature, 261, 54, 10.1038/261052a0

Buening, M. K., Wilsocki, P. G., Levin, W., Yagi, H., Thakker, D. R., Akagi, H., Koreeda, M., Jerina, D. M., and Conney, A. H. (1978) Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene-7,8-diol-9,10-epoxides in newborn mice:  Exceptional activity of (+)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene.Proc. Natl. Acad. Sci. U.S.A.75, 5358−5361.

Kapitulnik, J., Wislocki, P. G., Levin, W., Yagi, H., Jerina, D. M., and Conney, A. H. (1978) Tumorigenicity studies with diol-epoxides of benzo[a]pyrene which indicate that (±)-trans-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene is an ultimate carcinogen in newborn mice.Cancer Res.38, 354−358.

Chang R. L., 1987, Proc. Natl. Acad. Sci. U.S.A. 84

Marshall C. J., 1984, Activation of c-Ha-ras-1 proto-oncogene by in vitro chemical modification with a chemical carcinogen, benzo[a]pyrene diol-epoxide. Nature 310, 585−589

Puisieux, A., Lin, S., Groopman, J., and Ozturk, M. (1991) Selective targeting ofp53gene mutational hotspots in human cancers by etiologically defined carcinogens.Cancer Res.51, 6185−6189.

Denissenko, M. F., Pao, A., Tang, M.S., and Pfieifer, G. P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots inp53.Science274, 430−432.

Wood A. W., 1977, High mutagenicity of metabolically activated chrysene-1,2-dihydrodiol. Evidence for bay region activation of chrysene. Biochem. Biophys. Res. Commun. 78, 847−854

Nordqvist M., 1981, Metabolism of chrysene and phenanthrene to bay region diol-epoxides by rat liver enzymes. Mol. Pharmacol. 19, 168−178

Melikian A. A., 1982, Influence of a bay-region methyl group on formation of 5-methyl-chrysene dihydrodiol epoxide: DNA adducts in mouse skin. Cancer Res. 42, 1239−1242

Hecht S. S., 1985, Tumorigenicity of 5-methylchrysene dihydrodiols and dihydrodiol epoxides:  DNA adducts in newborn mice and mouse skin. Cancer Res. 45, 1449−1452

Chouroulinkov I., 1977, Cancer Lett., 3, 10.1016/S0304-3835(77)96163-8

Levin W., 1978, Evidence that benz[a]anthracene-3,4-diol-1,2-epoxide is an ultimate carcinogen on mouse skin. Cancer Res. 38, 1705−1710

Slaga T. J., 1978, Carcinogenicity and mutagenicity of benz[a]anthracene diols and diol epoxides. Cancer Res. 38, 1699−1704

Slaga T. J., 1979, Cancer Res. 39

Chouroulinkov I., 1976, Br. J. Cancer, 34, 10.1038/bjc.1976.207

Slaga T. J., 1977, Comparison of the tumor initiating activities of benzo[a]pyrene arene oxides and diol-epoxides. Cancer Res. 37, 4130−4133

Slaga T. J., 1976, Cancer Lett., 2, 10.1016/S0304-3835(76)80020-1

Levin W., 1977, Marked differences in the tumor initiating activity of optically pure (+)- and (−)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene on mouse skin. Cancer Res. 37, 2721−2725

Kim K. B., 1997, Oxidative stress to DNA, protein, and antioxidant enzymes (superoxide dismutase and catalase) in rats treated with benzo[a]pyrene. Cancer Lett., 205−212

Leadon S. A., 1988, Proc. Natl. Acad. Sci. U.S.A. 85

Devanesan P. D., 1992, Identification and quantitation of benzo[a]pyrene-DNA adducts formed by rat liver microsomes in vitro. Chem. Res. Toxicol. 5, 302−309

Sagher D., 1983, Insertion of nucleotides opposite apurinic/apyrimidinic sites in deoxyribonucleic acid during in vitro synthesis. Uniqueness of adenine nucleotides. Biochemistry 22, 4518−4526

Devanesan P. D., 1993, Identification and quantitation of 7,12-dimethylbenz[a]anthracene-DNA adducts formed in mouse skin. Chem. Res. Toxicol. 6, 364−371

Chakravarti D., 1995, Proc. Natl. Acad. Sci. U.S.A. 92

DiGiovanni J., 1982, Tumor initiating activity of 4-fluoro-7,12-dimethylbenz[a]anthracene and 1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene in female SENCAR mice. Carcinogenesis 3, 651−655

Cavalieri E. L., 1990, Polycyclic Aromat. Compd., 1, 70, 10.1080/10406639008034749

Nair R. V., 1992, Mouse skin tumor initiating activity of fluorination derivatives of 1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene. Chem. Res. Toxicol. 5, 153−156

MelendezColon V. J., 1997, Proc. Natl. Acad. Sci. U.S.A. 94

Flowers-Geary L., 1996, Identification of benzo[a]pyrene-7,8-dione as an authentic metabolite of (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene in isolated rat hepatocytes. Carcinogenesis 16, 2707−2715

Shou M., 1993, Reactivity of benzo[a]pyrene-7,8-dione with DNA. Evidence for the formation of deoxyguanosine adducts. Carcinogenesis 14, 475−482

McCoull K. D., 1998, Proc. Am. Assoc. Cancer Res., 39, 637

Flowers-Geary L., 1992, Biochem. (Life Sci.), 11, 58

Flowers-Geary L., 1996, Chem.-Biol. Interact., 99, 72, 10.1016/0009-2797(95)03660-1

Halliwell B., 1989, Free radicals in biology and medicine, 2

Kasai H., 1984, Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res. 12, 2137−2145

Kasai H., 1986, Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. Carcinogenesis 7

Frenkel K., 1992, Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol. Ther. 53, 127−166

Breen A. P., 1995, Reactions of oxyl radicals with DNA. Free Radical Biol. Med. 18, 1033−1077

Chaudhary A. K., 1994, Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver. Science 265, 1580−1582

Benamira M., 1995, Carcinogenesis, 16, 99, 10.1093/carcin/16.1.93

DeMarini D. M., 1989, Mutat. Res., 220, 29, 10.1016/0165-1110(89)90006-7

Emerit I., 1982, Activated oxygen species at the origin of chromosome breakage and sister-chromatid exchange. Mutat. Res. 103, 165−172

Povrik L. F., 1991, Genotoxicity of bleomycin. Mutat. Res. 257, 127−143

Ames B. N., 1990, Too many rodent carcinogens:  Mitogenesis increases mutagenesis. Science 227, 375−381

Cohen S. M., 1990, Cell proliferation in carcinogenesis. Science 249, 1007−1011

Cerutti P. A., 1985, Prooxidant states and tumor promotion. Science 227, 375−381

Liehr J. G., 1990, Genotoxic effects of estrogens. Mutat. Res. 238, 269−276

Dwivedy, I., Devanesan, P., Cremonesi, P., Rogan, E., and Cavalieri, E. (1992) Synthesis and characterization of estrogen-2,3- and 3,4-quinones. Comparison of DNA adducts formed by the quinones versus horseradish peroxidase-activated catechol estrogens.Chem. Res. Toxicol.5, 828−833.

Stack D. E., 1996, Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem. Res. Toxicol. 9, 851−859

Shen L., 1997, Bioreductive activation of catechol estrogen-ortho-quinones:  aromatization of the B-ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity. Carcinogenesis 18, 1093−1101

Shen L., 1997, J. Am. Chem. Soc., 119

Shen L., 1998, Chem. Res. Toxicol., 11, 101

Jan S.-T., 1998, Metabolic activation and formation of DNA adducts of hexestrol, a synthetic nonsteroidal carcinogen estrogen. Chem. Res. Toxicol. 11, 412−419

Nutter L. M., 1991, J. Biol. Chem., 266, 10.1016/S0021-9258(18)55309-6

Penning T. M., 1993, Chem.-Biol. Interact., 89, 34, 10.1016/0009-2797(93)03203-7

Ayengar P. K., 1959, Biochim. Biophys. Acta, 33, 10.1016/0006-3002(59)90504-9

Vogel K., 1980, J. Biol. Chem., 255, 10.1016/S0021-9258(18)43437-0

Penning T. M., 1984, Biochem. J., 222, 10.1042/bj2220601

Bolcsak L. E., 1983, J. Biol. Chem., 258, 10.1016/S0021-9258(18)32166-5

Hara A., 1985, Biochem. J., 225, 10.1042/bj2250177

Klein J., 1992, Eur. J. Biochem., 205, 10.1111/j.1432-1033.1992.tb16885.x

Nakagawa M., 1989, Purification and properties of multiple forms of dihydrodiol dehydrogenase from monkey liver. Chem. Pharm. Bull. 37, 2852−2854

Hara A., 1990, J. Biochem. (Tokyo), 108, 10.1093/oxfordjournals.jbchem.a123189

Takikawa H., 1990, J. Biol. Chem., 265, 10.1016/S0021-9258(19)39950-8

Deyashiki Y., 1992, Biochem. J., 282, 10.1042/bj2820741

Deyashiki Y., 1995, J. Biochem., 118, 10.1093/oxfordjournals.jbchem.a124904

Deyashiki Y., 1995, J. Biol. Chem., 270, 10.1074/jbc.270.18.10461

Hara A., 1996, Biochem. J., 313, 10.1042/bj3130373

Pawlowski J. E., 1991, J. Biol. Chem., 266, 10.1016/S0021-9258(18)31521-7

Pawlowski J. E., 1994, J. Biol. Chem., 269, 10.1016/S0021-9258(17)36860-6

Jez J. M., 1997, A new nomenclature for the Aldo-Keto Reductase superfamily. Biochem. Pharmacol. 54, 639−647

Khanna M., 1995, J. Biol. Chem., 270, 10.1074/jbc.270.34.20162

Burczynski, M. E., Harvey, R. G., and Penning, T. M. (1998) Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms:  Oxidation oftrans-7,8- 17 dihydroxy-7,8-dihydrobenzo[a]pyrene to the activatedo-quinone metabolite benzo[a]pyrene-7,8-dione.Biochemistry37, 6781−6790.

Stolz A., 1989, Rev. Physiol., 51, 10.1146/annurev.ph.51.030189.001113

Ohara H., 1994, Biochim. Biophys. Acta, 1215, 65

Hoog S. S., 1994, Proc. Natl. Acad. Sci. U.S.A. 91

Wilson D. K., 1992, Science, 257, 84, 10.1126/science.1621098

El-Kabbani O., 1995, Structure of procine aldehyde reductase holoenzyme. Nat. Struct. Biol. 2, 687−692

Jez J. M., 1997, Biochem. J., 326

Bennett M. J., 1996, Structure of 3α-hydroxysteroid/dihydrodiol dehydrogenase complexed with NADP+. Biochemistry 35, 10702−10711

Bennett M. J., 1997, Steroid recognition and regulation of hormone action:  crystal structure of testosterone and NADP+ bound to 3α-hydroxysteroid dehydrogenase. Structure 5, 799−812

Schlegel B. P., 1998, Mutagenesis of 3α-hydroxysteroid dehydrogenase reveals a “push-pull

Smithgall T. E., 1986, J. Biol. Chem., 261, 10.1016/S0021-9258(19)84546-5

Smithgall, T. E., Harvey, R. G., and Penning, T. M. (1988) Oxidation of thetrans-3,4-dihydrodiol metabolites of the potent carcinogen 7,12-dimethylbenz[a]anthracene and other benz[a]anthracene derivatives by 3α-hydroxysteroid-dihydrodiol dehydrogenase:  Effects of methyl substitution on velocity and stereochemical course oftrans-dihydrodiol oxidation.Cancer Res.48, 1227−1232.

Burczynski M. E., 1999, Polycyclic aromatic hydrocarbon trans-dihydrodiol specificity of four recombinant human dihydrodiol dehydrogenase isoforms. Polycyclic Aromat. Compd. (in press)

Yang S. K., 1985, Polycyclic Hydrocarbons and Carcinogenesis, 283, 34

Zacharias D. E., 1979, J. Am. Chem. Soc., 101, 10.1021/ja00509a004

Tsuruda, L., Hou, Y.T., and Penning, T. M. (1999) Stable transfection of dihydrodiol dehydrogenase in MCF7-breast carcinoma cells promotes polycyclic aromatic hydrocarbono-quinone formation which leads to cell death.Polycyclic Aromat. Compd.(in press).

Hou Y.-T., 1994, Rat dihydrodiol dehydrogenase:  complexity of gene structure and tissue-specific and sexually dimorphic gene expression. Cancer Res. 54, 247−255

Lin H.-K., 1997, Mol. Endocrinol. 11

Murty, V. S., and Penning, T. M. (1992) Polycyclic aromatic hydrocarbon (PAH)ortho-quinone conjugate chemistry:  kinetics of thiol addition to PAHortho-quinones and structures of thiol-ether adducts of naphthalene-1,2-dione.Chem.Biol. Interact.84, 169−188.

Murty V. S., 1992, Characterization of mercapturic acid and glutathionyl conjugates of benzo[a]pyrene-7,8-dione by two-dimensional NMR. Bioconjugate Chem. 3, 218−224

Monks T. J., 1997, Biological reactivity of polyphenolic-glutathione conjugates. Chem. Res. Toxicol. 10, 1296−1313

Abul-Hajj Y.-J., 1984, J. Steroid Biochem., 21

Chesis P. L., 1984, Proc. Natl. Acad. Sci. U.S.A. 81

Lind C., 1982, DT-diaphorase as a quinone reductase:  A cellular control device against semiquinone and superoxide radical formation. Arch. Biochem. Biophys. 216, 178−185

Flowers-Geary L., 1993, Cytotoxicity of polycyclic aromatic hydrocarbon o-quinones in rat and human hepatoma cells. Chem. Res. Toxicol. 6, 252−260

Di Monte D., 1984, Alterations in intracellular thiol homeostasis during the metabolism of menadione by isolated rat hepatocytes. Arch. Biochem. Biophys. 235, 334−342

Reed D. J., 1990, Review of the current status of calcium and thiols in cellular injury. Chem. Res. Toxicol. 3, 495−502

O'Brien P. J., 1991, Chem.-Biol. Interact., 80, 41, 10.1016/0009-2797(91)90029-7

Flowers L., 1996, Disposition and biological activity of benzo[a]pyrene-7,8-dione. A genotoxic metabolite generated by dihydrodiol dehydrogenase. Biochemistry 35, 13664−13672

Wacker W. E. C., 1959, J. Biol. Chem., 231

Prutz W. A., 1990, J. Radiat. Biol., 58, 10.1080/09553009014551581

Li Y., 1993, Oxidation of hydroquinone by copper:  chemical mechanism and biological effects. Arch. Biochem. Biophys. 300, 346−355

Li Y., 1994, Cancer Res. 54

Giloni L., 1981, J. Biol. Chem., 256, 10.1016/S0021-9258(19)68888-5

Lin H.-K., 1995, Cloning, sequencing, and functional analysis of the 5‘-flanking region of the rat 3α-hydroxysteroid/dihydrodiol dehydrogenase gene. Cancer Res. 5, 4105−4113

Hung C.-F., 1998, Proc. Am. Assoc. Cancer Res., 39, 249

Sterling K., 1993, Rat CYP1A1 negative regulatory element:  biological activity and interaction with a protein from liver and hepatoma cells. Mol. Pharmacol. 44, 560−568

Bhat R., 1996, Int. J. Biochem., 28

Hou Y.-T., 1998, Dexamethasone regulation of the rat 3α-hydroxysteroid/dihydrodiol dehydrogenase gene. Mol. Pharmacol. 53, 459−466

Nebert D. W., 1981, Rev. Pharmacol. Toxicol., 21

Denison M. S., 1988, J. Biol. Chem., 263, 10.1016/S0021-9258(19)77819-3

Denison M. S., 1989, J. Biol. Chem., 264, 10.1016/S0021-9258(19)84730-0

Prochaska H. J., 1985, Proc. Natl. Acad. Sci. U.S.A. 82

De Long M. J., 1987, Role of cytochrome P1-450 in the induction of NAD(P)H:quinone reductase in a murine hepatoma cell line and its mutants. Carcinogenesis 8, 1549−1553

Prochaska H. J., 1988, Regulatory mechanisms of monofunctional and bifunctional anti-carcinogenic enzyme inducers in murine liver. Cancer Res. 48, 4776−4782

Rushmore T. H., 1990, J. Biol. Chem., 265, 10.1016/S0021-9258(18)77351-1

Rushmore T. H., 1991, J. Biol. Chem., 266, 10.1016/S0021-9258(18)99004-6

Friling R. S., 1990, Proc. Natl. Acad. Sci. U.S.A. 87

Li Y., 1992, J. Biol. Chem., 267

Burczynski, M. E., Lin, M. K., and Penning, T. M. (1999) Isoform-specific induction of a human aldo-keto reductase by PAH, electrophiles and oxidative stress. Implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase.Cancer Res.(in press).